Clinical trials with Phyto-Psychopharmacological agents.

[1]  T. Telger,et al.  Rational Phytotherapy: A Physicians' Guide to Herbal Medicine , 1998 .

[2]  V. Eu,et al.  Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. , 1997 .

[3]  H. Volz.  Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an Overview , 1997, Pharmacopsychiatry.

[4]  D. Wheatley.  LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical Trial , 1997, Pharmacopsychiatry.

[5]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[6]  W. Herrmann,et al.  Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. , 1996, Pharmacopsychiatry.

[7]  H. Woelk,et al.  Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients. , 1994, Journal of geriatric psychiatry and neurology.

[8]  K. Krishnan,et al.  Bicaudate Index on Magnetic Resonance Imaging: Effects of Normal Aging , 1994, Journal of geriatric psychiatry and neurology.

[9]  W. Burke,et al.  Reliability and Validity of the Short Portable Mental Status Questionnaire Administered by Telephone , 1994, Journal of Geriatric Psychiatry and Neurology.

[10]  J. Kleijnen,et al.  Ginkgo biloba for cerebral insufficiency. , 1992, British journal of clinical pharmacology.

[11]  M. Schou,et al.  Renal Lithium Elimination in Manic-Depressive Patients – Initial Excretion and Clearance , 1971 .

[12]  J. Vesper,et al.  ANTIDEPRESSIVE WIRKSAMKEIT EINES HOCHDOSIERTEN HYPERICUM-EXTRAKTES , 1996 .

[13]  J. Krieglstein,et al.  Pharmakologische Wirkungen von Ginkgo biloba-Extrakt und - Inhaltsstoffen , 1992 .